SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042985
Filing Date
2019-11-12
Accepted
2019-11-12 16:44:40
Documents
48
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2019 10-Q snss-10q_20190930.htm 10-Q 1334892
2 EX-31.1 snss-ex311_7.htm EX-31.1 16678
3 EX-31.2 snss-ex312_6.htm EX-31.2 16852
4 EX-32.1 snss-ex321_8.htm EX-32.1 8749
5 GRAPHIC gkcnr02f4ap2000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-19-042985.txt   4074333

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20190930.xml EX-101.INS 690540
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20190930.xsd EX-101.SCH 37177
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20190930_cal.xml EX-101.CAL 42178
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20190930_def.xml EX-101.DEF 104982
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20190930_lab.xml EX-101.LAB 296237
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20190930_pre.xml EX-101.PRE 198119
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 191210293
SIC: 2834 Pharmaceutical Preparations